Tirzepatide

Alternative Names: Zepbound, Mounjaro

Tirzepatide is a medication used for weight loss that works by activating both GLP-1 and GIP receptors, helping reduce appetite, slow gastric emptying, and improve blood sugar control. Clinical studies show substantial weight loss (often ~15–20% or more) over time. It’s given as a once-weekly injection and is generally well tolerated, though common side effects include nausea, vomiting, and GI upset, especially during dose escalation. Overall, one of the most effective medical options currently available for weight loss.

Treatment Type: Prescription Medication

Treatment Class: GLP1

Treatment Modality: Injection

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
1.0
1 = Very Expensive 5 = Very Affordable

1.0

Very Expensive
Relief Speed
2.0
1 = No Relief 5 = Immediate Relief

2.0

Slow Relief
Side Effects
4.0
1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect
Treatment Line
3.0
1 = Third-line or more 5 = First-line

3.0

Second Line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews
5
100%
4
0%
3
0%
2
0%
1
0%

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
1 month ago
I’ve seen great results with tirzepatide, often with less side effects than semaglutide. Weight loss can be significant, and many patients tolerate it well. Starting low or “micro-dosing” can help the body adjust and minimize GI side effects. Overall, a very effective option when tolerated.
#VeryExpensive #SlowRelief #MildEffect #Second-line #Maintenance #Preventative